A once - promising treatment to fight Alzheimer ’s by biotech company TauRx has failed in clinical trials , where it performed no better than a decade . The treatment is however being tested in another study , with results promising in coming months . With 99.6 % of Alzheimer ’s treatments having failed in the decade between 2002 and 2012 , the market for effective treatments is valued at over $ 200 per year .
A once-promising drug to fight Alzheimer’s by biotech company TauRx has failed in clinical trials, where it performed no better than a placebo. The treatment is however being tested in another study, with results expected in coming months. With 99.6% of Alzheimer’s treatments having failed in the decade between 2002 and 2012, the market for effective treatments is valued at over $10bn per year.